Jefferies upgrades Bristol Myers Squibb to ‘buy’ on drug Cobenfy by Investing.comDecember 17, 20240 Investing.com — Jefferies upgraded Bristol-Myers Squibb Company (NYSE:) from Hold to Buy and raised its price target by $7 to…